Prevalence of Gout in the Adult Population of France

Arthritis Care and Research

Volumn 68, Issue 2, 2016, Pages 261-266

  Bardin, Thomas ^a,h,i   Bouée, Stéphane ^b   Clerson, Pierre ^c   Chalès, Gérard ^d   Flipo, René Marc ^e   Lioté, Frédéric ^a   Perez, Vincent ^f   Poiraud, Thierry ^f   Schaeverbeke, Thierry ^g   Richette, Pascal ^a,h,i  

^a Hopital Lariboisiere   (United States)

^b CEMKA EVAL   (France)

^c Orgamétrie Biostatistiques   (France)

^d UNIVERSITÉ DE RENNES 1   (France)

^e UNIV LILLE   (France)

^f Ménarini France ^*  (France)

^g HÔPITAL PELLEGRIN   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTHRALGIA; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FRANCE; GOUT; HEALTH SURVEY; HUMAN; MALE; PREVALENCE; QUESTIONNAIRE; SELF REPORT; SENSITIVITY AND SPECIFICITY; TELEPHONE INTERVIEW; ADOLESCENT; AGE; CROSS-SECTIONAL STUDY; MIDDLE AGED; SEX DIFFERENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; GOUT; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEX FACTORS; YOUNG ADULT;

EID: 84957108641     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22660     Document Type: Article

References (31)

1. Roddy E, Doherty M., Epidemiology of gout. Arthritis Res Ther 2010; 12: 223.
2. Zhu Y, Pandya BJ, Choi HK., Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63: 3136-41.
3. Trifiro G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, et al., Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis 2012; 72: 694-700.
4. Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M., Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis 2015; 74: 661-7.
5. Khanna D, FitzGerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al., 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012; 64: 1431-46.
6. Trieste L, Palla I, Fusco F, Tani C, Baldini C, Mosca M, et al., The economic impact of gout: a systematic literature review. Clin Exp Rheumatol 2012; 30: S145-8.
7. Wertheimer A, Morlock R, Becker MA., A revised estimate of the burden of illness of gout. Curr Ther Res Clin Exp 2013; 75: 1-4.
8. Edwards NL, Sundy JS, Forsythe A, Blume S, Pan F, Becker MA., Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy. J Med Econ 2011; 14: 10-5.
9. Richette P, Perez-Ruiz F, Doherty M, Jansen TL, Nuki G, Pascual E, et al., Improving cardiovascular and renal outcomes in gout: what should we target? Nat Rev Rheumatol 2014; 10: 654-61.
10. Guillemin F, Saraux A, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, et al., Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 2005; 64: 1427-30.
11. Saraux A, Guillemin F, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, et al., Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis 2005; 64: 1431-5.
12. Guillemin F, Rat AC, Mazieres B, Pouchot J, Fautrel B, Euller-Ziegler L, et al., Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey. Osteoarthritis Cartilage 2011; 19: 1314-22.
13. Zalokar J, Lellouch J, Claude JR., Serum urate and gout in 4663 young male workers. Sem Hop 1981; 57: 664-70. In French.
14. Richette P, Clerson P, Bouee S, Chales G, Doherty M, Flipo RM, et al., Identification of patients with gout: elaboration of a questionnaire for epidemiological studies. Ann Rheum Dis 2015; 74: 1684-90.
15. Kalton G, Flores-Cervantes I., Weighting methods. In:, Westlake A, Martin J, Rigg M, Skinner C, editors. New methods for survey research. Southampton (UK): Association for Survey Computing; 1998. pp. 79-96.
16. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG., Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005; 64: 267-72.
17. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al., Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008; 67: 960-6.
18. Cea Soriano L, Rothenbacher D, Choi HK, Garcia Rodriguez LA., Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther 2011; 13: R39.
19. Chuang SY, Lee SC, Hsieh YT, Pan WH., Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008. Asia Pac J Clin Nutr 2011; 20: 301-8.
20. Lai SW, Liu CS, Lin T, Lin CC, Lai HC, Liao KF., Prevalence of gout and hyperuricemia in Taiwan: a hospital-based, cross-sectional study [letter]. South Med J 2009; 102: 772-3.
21. Gosling AL, Matisoo-Smith E, Merriman TR., Gout in Maori [letter]. Rheumatology (Oxford) 2014; 53: 773-4.
22. Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Gow PJ, et al., National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) 2012; 51: 901-9.
23. Klemp P, Stansfield SA, Castle B, Robertson MC., Gout is on the increase in New Zealand. Ann Rheum Dis 1997; 56: 22-6.
24. Robinson PC, Taylor WJ, Merriman TR., Systematic review of the prevalence of gout and hyperuricaemia in Australia. Intern Med J 2012; 42: 997-1007.
25. Wijnands JM, Viechtbauer W, Thevissen K, Arts IC, Dagnelie PC, Stehouwer CD, et al., Determinants of the prevalence of gout in the general population: a systematic review and meta-regression. Eur J Epidemiol 2011; 30: 19-33.
26. Picavet HS, Hazes JM., Prevalence of self reported musculoskeletal diseases is high. Ann Rheum Dis 2003; 62: 644-50.
27. Bergmann MM, Jacobs EJ, Hoffmann K, Boeing H., Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire. Eur J Epidemiol 2004; 19: 411-6.
28. McAdams MA, Maynard JW, Baer AN, Kottgen A, Clipp S, Coresh J, et al., Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol 2011; 38: 135-41.
29. Harrold LR, Saag KG, Yood RA, Mikuls TR, Andrade SE, Fouayzi H, et al., Validity of gout diagnoses in administrative data. Arthritis Rheum 2007; 57: 103-8.
30. Malik A, Dinnella JE, Kwoh CK, Schumacher HR., Poor validation of medical record ICD-9 diagnoses of gout in a veterans affairs database. J Rheumatol 2009; 36: 1283-6.
31. Rozenberg S, Lang T, Laatar A, Koeger AC, Orcel P, Bourgerois P., Diversity of opinions on the management of gout in France: a survey of 750 rheumatologists. Rev Rhum Engl Ed 1996; 63: 255-61.